eluting-stent - Globe Thesis

Keyword [eluting-stent] Result: 181 - 200 \| Page: 10 of 10
181.	Long-term Efficacy And Safety Of Novel Biodegradable Polymer–coated Cobalt-chromium Sirolimus-eluting Stents In Patients With Coronary Artery Disease 4 Year Clinical Outcomes Of The I-LOVE-IT 2 Trial
182.	Analysis Of Factors Influencing DAPT Compliance After PCI
183.	Application Of Drug Coated Balloon In Restenosis After Coronary Artery Stenting
184.	Clinical Efficacy Of Drug-coated Balloon With The Second Generation Of Drug Eluting Stents In The Treatment Of Coronaryartery In-stent Restenosis
185.	Effect Of Huatan Huoxue Jiedu Prescription On Neonatal Atherosclerotic Plaque After Drug-eluting Stent In Rabbit Abdominal Aorta
186.	The Clinical Analysis Of The Endovascular Stents And Clinical Assays For Symptomatic Intracranial Artery Stenosis
187.	Application And Long-term Clinical Outcome Of Domestic BuMA Stent In Interventional Treatment Of Coronary Heart Disease
188.	The Effect Of Sirolimus Eluting Stent On Tracheal Stenosis After Stenting
189.	Correlation Research Between CTRP3 And In-stent Restenosis After Coronary Drug-eluting Stent Implantation
190.	Risk Factors And Clinical Characteristics Analysis Of Coronary Artery Aneurysms Formation After Drug-Eluting Stent Implantation For Coronary Heart Disease
191.	One Year Size Change Of Aneurysm After New-Generation Drug-Eluting Stents Implantation In Severe Stenosis Lesions With Focal Coronary Artery Aneurysm-A Retrospective Study
192.	Influence Of Hemoglobin A1c Levels On The Residual Platelet Reactivity And Outcomes After Coronary Placement Of Drug-eluting Stent
193.	Drug-Coated Balloon Versus Drug-Eluting Stent In Patients With De Novo Small Coronary Vessel Lesions: A Systematic Review And Meta-Analysis
194.	Meta Analysis Of Second-generation Drug-Coated Balloon Versus Second-generation Drug-Eluting Stent In The Treatment Of Small Coronary Vessels
195.	A Comparative Study Of Clopidogrel-Hydrogen Reduction And Direct Deactivation After Intracoronary DES Implantation After 12 Months
196.	The Effect Of Lp(a)on In-stent Restenosis And Development Of Non-Target Coronary Lesions In CAD Patients With Drug-Eluting Stents
197.	Safety And Efficacy Of Permanent Polymer,Biodegradable Polymer And Polymer-free Drug-eluting Stents During Unprotected Left Main Lesion PCI
198.	Therapeutic Effect Of Drug-eluting Balloon On Coronary Small Vessel Disease
199.	Analysis Of The Influencing Factors Of The Restenosis In Coronary Drug Eluting Stents
200.	The Application Value Of Paclitaxel-eluting Stent In Preventing Restenosis After Tracheal Stent Implantation In Dogs
<<First <Prev Next> Last>> Jump to